2025 quality measures for MIPS reporting

Advance Care Plan

Documentation of Current Medications in the Medical Record

Tuberculosis Screening Prior to First Course Biologic Therapy

Tobacco Use: Screening and Cessation Intervention

Screening for High Blood Pressure and Follow-Up Documented

Patient-Centered Surgical Risk Assessment and Communication

Closing the Referral Loop: Receipt of Specialist Report

Melanoma Reporting

Psoriasis: Clinical Response to Systemic Medications

Unhealthy Alcohol Use: Screening & Brief Counseling

Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician

Psoriasis – Improvement in Patient-Reported Itch Severity

Dermatitis – Improvement in Patient-Reported Itch Severity

Screening for Social Drivers of Health

Adult Immunization Status

Connection to Community Service Provider

Gains in Patient Activation Measure (PAM) Scores at 12 Months

Melanoma: Tracking and Evaluation of Recurrence

Skin Cancer: Biopsy Reporting Time – Clinician to Patient

Chronic Skin Conditions: Patient Reported Quality-of-Life

Melanoma: Appropriate Surgical Margins

Psoriasis – Appropriate Assessment & Treatment of Severe Psoriasis

Avoidance of Post-operative Systemic Antibiotics for Office-based Closures and Reconstruction After Skin Cancer Resection Procedures

Continuation of Anticoagulation Therapy in the Office-based Setting for Closures and Reconstruction After Skin Cancer Resection Procedures

Avoidance of Opioid Prescriptions for Closures and Reconstruction After Skin Cancer Resection

Actinic Keratosis: Self-reported AK Treatment or Management Outcomes